VitalCaring Rebuts The DOJ, Makes Case For Itself As Worthy Divestment Partner 

VitalCaring Group – the home health and hospice company led by April Anthony – got caught in the crosshairs of the U.S. Department of Justice (DOJ) this week. The company responded, however, defending its current state and re-emphasizing where it plans to go. VitalCaring agreed to acquire divested assets from Amedisys Inc. (Nasdaq: AMED) in […]

UnitedHealth Group, Amedisys Set For All-Important Meeting With DOJ Officials

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The companies will likely make a final case for why the deal should go through, while the DOJ considers whether to officially file a lawsuit […]

State Scrutiny Of UnitedHealth Group-Amedisys Deal Pushes Timeline Back Further 

UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: the Oregon Health Authority’s (OHA) ongoing review, which is expected to continue until at least the end of November. OHA’s Health Care Market Oversight (HCMO) program reviews health care business deals to […]

DOJ Reportedly Considering Lawsuit To Block Optum-Amedisys Deal

UnitedHealth Group’s (NYSE:UNH) planned acquisition of Amedisys Inc. (Nasdaq:AMED) is catching further scrutiny. Late Wednesday, a report suggesting that the Department of Justice is considering a lawsuit to block Optum’s takeover of Amedisys surfaced. The deal was first agreed to in June of last year. The news comes just a few weeks after the DOJ […]

What The UnitedHealth Group Antitrust Investigation Means For Amedisys, Home Health Industry

Since the news surfaced Tuesday that the Department of Justice had opened an antitrust investigation into UnitedHealth Group (NYSE: UNH), additional questions have bubbled up. Namely, those questions surround the home health provider Amedisys Inc. (Nasdaq: AMED), which agreed to be acquired by UnitedHealth Group’s Optum in June of last year. Will that deal be […]

With Amedisys Deal Pending, Justice Department Opens Antitrust Investigation Into UnitedHealth Group

The Department of Justice is targeting UnitedHealth Group (NYSE: UNH) in an antitrust investigation, The Wall Street Journal reported Tuesday.  Specifically, the Justice Department is interviewing subjects around interactions between UnitedHealth Group and its health care provider services arm, Optum. UnitedHealthcare is one of the largest insurers in the country. Meanwhile, Optum is one of […]

Lawmakers Elizabeth Warren, Pramila Jayapal Urge DOJ To Further Scrutinize Optum-Amedisys Deal

Lawmakers are hoping to direct further scrutiny toward UnitedHealth Group’s (NYSE: UNH) pending deal of the home health giant Amedisys Inc. (Nasdaq: AMED). Specifically, Sen. Elizabeth Warren (D-Mass.) and U.S. Rep. Pramila Jayapal (D-Wash.) have asked antitrust regulators to take a closer look. “We urge DOJ and FTC to closely scrutinize UnitedHealth’s proposed acquisition of […]

Home Health Sector Remains Area of Focus For Fraud Watchdogs

The federal government saw a return of nearly $1.9 billion in health care fraud settlements and judgments in 2021. Of this $1.9 billion, the Medicare Trust Funds received $1.2 billion, and the U.S. Centers for Medicare & Medicaid Services (CMS) received roughly $98.7 million. The Health & Human Services Office of Inspector General’s (HHS-OIG) annual […]

DOJ Highlights Multiple Home Health-Related Fraud Cases in July

Home health enforcement efforts have been on the rise in 2021, especially over the past couple of months. There have been developments with at least two multi-million-dollar fraud schemes, with the watchdog arm of the U.S. Department of Health and Human Services (HHS) also releasing findings from a large hospice-related audit. On July 15, federal […]